INSIGHTS ON UPSTREAM MANUFACTURING
-
![Reference_image_1]( "Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies")
Platform Strategy For Improving Manufacturability And Efficacy In Bispecific AntibodiesNovel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.
-
![Innovate And Accelerate]( "Leveraging 3Rs For Superior Cell Line Characterization")
Leveraging 3Rs For Superior Cell Line CharacterizationExplore how non-animal methods, including next generation sequencing, are advancing biologics safety testing through the 3Rs while supporting faster adventitious virus testing and more.
-
![Primrose Bio - picobodies]( "Production Of Disulfide-Rich Cow Knob Domain Antibodies")
Production Of Disulfide-Rich Cow Knob Domain AntibodiesDiscover how a microbial expression platform enabled high-titer production of disulfide-rich bovine knob domain antibodies with confirmed SARS-CoV-2 spike protein binding activity at 19 nM IC50.
-
![INFORS 2]( "The Difference Between Batch, Fed-Batch, And Continuous Processes")
The Difference Between Batch, Fed-Batch, And Continuous ProcessesFeeding strategy directly influences growth, yield, oxygen demand, and product quality. Choosing the right mode—batch, fed-batch, or continuous—helps balance productivity, control, and efficiency.
-
A Practical Guide To Process Development From Shake Flask To Scale-Up7/6/2026
Scaling mammalian cell culture requires more than volume changes. Uncover why managing oxygen, pH, CO₂, and data consistency is critical to avoid failed transfers and ensure reproducible performance.
-
Large-Scale Lentivirus Manufacturing With A Transfection Complex Stabilizer7/6/2026
De-risk large-scale lentivirus manufacturing by mastering transfection complex stability. Find out how to control particle aggregation, reduce fluid volumes to 2%, and minimize expensive GMP costs.
-
Trusted Performance With A Plus: Seamless Transfer From R&D To Commercial7/5/2026
Bridge the gap between early R&D and commercial biomanufacturing. Learn how scalable control architectures, automated gassing strategies, and digital validation protocols streamline tech transfers.
-
Optimize Every Step In Your Biopharma Site7/5/2026
Bridge the gap between validation and cleanroom execution. Learn how proactive site surveys, residue management, and robust CAPA programs resolve compliance deficiencies and ensure audit readiness.
UPSTREAM MANUFACTURING SOLUTIONS
-
![cell culture, medicine, medical, laboratory-GettyImages-1491010530]( "Consistone Yeast Extract UF: Batch Versus Fed-Batch Processing")
Gain insight into how targeted nutrient supplementation increased CHO cell growth, boosted antibody production, and improved glycosylation profiles across batch and fed-batch cultures.
-
![GettyImages-1002000796-lab-research-scientist-development]( "From Cell Line To Clinic: 4 Months Sooner With mAb Accelerator")
Launch cell line development during funding to save four months, beating early bottlenecks and reducing capital risk with milestone-aligned models.
-
![GettyImages-2193144544-scientist-cell-culture-in-lab]( "Efficient CLD For Complex Biologics And High-Titer mAbs")
We aren't just a CDMO for standard antibodies, we also specialize in taking on the complex molecules (bispecifics, trispecifics, FC-fusions, and more).
-
![Sefia Expansion]( "Bring Greater Control To Your Cell Therapy Manufacturing")
Learn how automating activation, transduction, and expansion in a closed workflow can simplify operations, reduce manual steps, and improve consistency while enabling real-time monitoring.
-
![Eppendorf together we lift standards]( "Upstream Bioprocess Equipment For Commercial Manufacturing")
Transform your bioprocessing workflow with intelligent, user-friendly systems that combine precision engineering with operational excellence for superior outcomes.
